{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:32:19Z","timestamp":1794277939510,"version":"4.9.0"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Sofia","award":["12-D\/2013-2014"],"award-info":[{"award-number":["12-D\/2013-2014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Dermatitis herpetiformis (DH) is a blistering dermatosis, which shares common immunologic features with celiac disease (CD). The aim of the present study was to explore the performance of a panel of CD-related antibodies and IL-17A in Bulgarian patients with DH. Materials and Methods: Serum samples from 26 DH patients at mean age 53 \u00b1 15 years and 20 healthy controls were assessed for anti-tissue transglutaminase (anti-tTG), anti-deamidated gliadin peptides (anti-DGP), anti-actin antibodies (AAA), and IL-17A by enzyme linked immuno-sorbent assay (ELISA), as well as anti-tTG, anti-gliadin (AGA), and anti-Saccharomyces cerevisiae antibodies (ASCA) using immunoblot. Results: The average serum levels of anti-tTG, anti-DGP, AGA, AAA, and the cytokine IL-17A were at significantly higher levels in patients with DH compared to the average levels in healthy persons which stayed below the cut-off value (p &lt; 0.05). Anti-DGP and anti-tTG antibodies showed the highest diagnostic sensitivity and specificity, as well as acceptable positive and negative predictive value. None of the healthy individuals was found positive for the tested antibodies, as well as for ASCA within the DH group. All tests showed good to excellent correlations (r = 0.5 \u00f7 0.9, p &lt; 0.01). Conclusions: Although the diagnosis of DH relies on skin biopsy for histology and DIF, serologic testing of a panel of celiac-related antibodies could be employed with advantages in the diagnosing process of DH patients. Furthermore, DH patients who are positive for the investigated serologic parameters could have routine monitoring for gastrointestinal complications typical for the gluten-sensitive enteropathy.<\/jats:p>","DOI":"10.3390\/medicina55050136","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T11:37:40Z","timestamp":1557920260000},"page":"136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Celiac-Related Autoantibodies and IL-17A in Bulgarian Patients with Dermatitis Herpetiformis: A Cross-Sectional Study"],"prefix":"10.3390","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-1272","authenticated-orcid":false,"given":"Tsvetelina","family":"Velikova","sequence":"first","affiliation":[{"name":"Clinical Immunology, University Hospital Lozenetz, 1407 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Shahid","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Medical University\u2014Sofia, 1431 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-838X","authenticated-orcid":false,"given":"Ekaterina","family":"Ivanova-Todorova","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology\u2014University Hospital St. Ivan Rilski, 1431 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kossara","family":"Drenovska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Medical University\u2014Sofia, 1431 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalina","family":"Tumangelova-Yuzeir","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology\u2014University Hospital St. Ivan Rilski, 1431 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Altankova","sequence":"additional","affiliation":[{"name":"Clinical Immunology, University Hospital Lozenetz, 1407 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snejina","family":"Vassileva","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Medical University\u2014Sofia, 1431 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CCID.S69127","article-title":"The diagnosis and treatment of dermatitis herpetiformis","volume":"8","author":"Antiga","year":"2015","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1468-3083.2009.03188.x","article-title":"The Italian Group for Cutaneous Immunopathology. Guidelines for the diagnosis and treatment of dermatitis herpetiformis","volume":"23","author":"Caproni","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Reunala, T., Salmi, T.T., Hervonen, K., Kaukinen, K., and Collin, P. (2018). Dermatitis Herpetiformis: A Common Extraintestinal Manifestation of Coeliac Disease. Nutrients, 10.","DOI":"10.3390\/nu10050602"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Merkl","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: A cutaneous manifestation of coeliac disease","volume":"49","author":"Collin","year":"2017","journal-title":"Ann. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"239691","DOI":"10.1155\/2012\/239691","article-title":"Dermatitis herpetiformis: From the genetics to the development of skin lesions","volume":"2012","author":"Bonciani","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3109\/07853899809002482","article-title":"Dermatitis herpetiformis: Coeliac disease of the skin","volume":"30","author":"Reunala","year":"1998","journal-title":"Ann. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.33.2.206","article-title":"Increase of lymphocytes bearing the gamma\/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis","volume":"33","author":"Savilahti","year":"1992","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-4632.2007.03214.x","article-title":"Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: Review of the Mayo Clinic experience","volume":"46","author":"Gibson","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.3748\/wjg.v21.i24.7349","article-title":"Effector and suppressor T cells in celiac disease","volume":"21","author":"Mazzarella","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_11","unstructured":"Berger, E. (1958). Zur Allergischen Pathogenese der C\u00f6liakie, S Karger Ag. Bibliotheca Paediatrica."},{"key":"ref_12","first-page":"205","article-title":"Serologic indicators of celiac disease","volume":"26","author":"Rossi","year":"1998","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(71)91499-1","article-title":"Tissue antibodies in dermatitis herpetiformis and adult coeliac disease","volume":"1","author":"Seah","year":"1971","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.1984.tb06601.x","article-title":"IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease","volume":"111","author":"Chorzelski","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cmi.2010.65","article-title":"Antibodies in celiac disease: Implications beyond diagnostics","volume":"8","author":"Caja","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/gut.52.2.199","article-title":"Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues","volume":"52","author":"Laurila","year":"2003","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2011.02.025","article-title":"Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides","volume":"66","author":"Kasperkiewicz","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","first-page":"197","article-title":"Celiac disease serology in dermatitis herpetiformis. Which is the best option for detecting gluten sensitivity?","volume":"36","author":"Sugai","year":"2006","journal-title":"Acta Gastroenterol. Latinoam."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ad.2010.11.007","article-title":"A Retrospective Study of Clinical, Histological, and Immunological Characteristics in Patients with Dermatitis Herpetiformis. The Experience of Hospital Clinic de Barcelona, Spain between 1995 and 2010 and a Review of the Literature","volume":"102","author":"Fuertes","year":"2011","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas Engl. Ed."},{"key":"ref_22","first-page":"100","article-title":"The role of serological tests in redefining coeliac disease","volume":"30","author":"Dahele","year":"2000","journal-title":"Proc. R. Coll. Phys. Edinb."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1016\/j.jid.2017.07.712","article-title":"Dermatitis herpetiformis in Bulgaria: Report of 78 patients","volume":"137","author":"Shahid","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1590\/abd1806-4841.20142966","article-title":"Dermatitis herpetiformis: Pathophysiology, clinical presentation, diagnosis and treatment","volume":"89","author":"Clarindo","year":"2014","journal-title":"An. Bras. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MPG.0b013e3181c992be","article-title":"Novel Screening Assay Performance in Pediatric Celiac Disease and Adult Dermatitis Herpetiformis","volume":"51","author":"Jaskowski","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaad.2005.06.014","article-title":"Medical pearl: Using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis","volume":"53","author":"Desai","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0016-5085(99)70482-8","article-title":"Tissue transglutaminase antibodies in dermatitis herpetiformis","volume":"117","author":"Porter","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1523-1747.1999.00627.x","article-title":"Antibodies to Tissue Transglutaminase as Serologic Markers in Patients with Dermatitis Herpetiformis","volume":"113","author":"Dieterich","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/clim.2000.4983","article-title":"Tissue Transglutaminase and Endomysial Antibodies\u2014Diagnostic Markers of Gluten-Sensitive Enteropathy in Dermatitis Herpetiformis","volume":"98","author":"Kumar","year":"2001","journal-title":"Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1572-0241.2000.02086.x","article-title":"Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis","volume":"95","author":"Koop","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2133.2001.03981.x","article-title":"Tissue transglutaminase antibody assessment in dermatitis herpetiformis","volume":"144","author":"Caproni","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cca.2006.08.006","article-title":"Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive disease","volume":"376","author":"Geisen","year":"2007","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1373\/clinchem.2009.129668","article-title":"New Serology Assays Can Detect Gluten Sensitivity among Enteropathy Patients Seronegative for Anti-Tissue Transglutaminase","volume":"56","author":"Sugai","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bpg.2005.02.006","article-title":"Diagnosis of coeliac disease","volume":"19","author":"Green","year":"2005","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1572-0241.1999.983_f.x","article-title":"Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice","volume":"94","author":"Rostami","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","article-title":"Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u2018celiac sprue\u2019)","volume":"102","author":"Marsh","year":"1992","journal-title":"Gastroenterology"},{"key":"ref_38","first-page":"177","article-title":"IgG-F-actin antibodies in celiac disease and dermatitis herpetiformis","volume":"69","author":"Pop","year":"2010","journal-title":"Rom. Arch."},{"key":"ref_39","first-page":"296","article-title":"Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease","volume":"55","author":"Granito","year":"2006","journal-title":"Gut"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12691\/ijcd-6-1-8","article-title":"Serological Update on Celiac Disease Diagnostics in Adults","volume":"6","author":"Velikova","year":"2018","journal-title":"Int. J. Celiac Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"967987","DOI":"10.1155\/2013\/967987","article-title":"IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid","volume":"2013","author":"Zebrowska","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6716419","DOI":"10.1155\/2017\/6716419","article-title":"Expression of the JAK\/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis","volume":"2017","author":"Juczynska","year":"2017","journal-title":"Mediat. Inflamm."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/5\/136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:52:09Z","timestamp":1760187129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/55\/5\/136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["medicina55050136"],"URL":"https:\/\/doi.org\/10.3390\/medicina55050136","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]}}}